Total Voting Rights
Summary by AI BETAClose X
2 November 2026
VENTURE LIFE GROUP PLC
("Venture Life", "VLG" or the "Company")
Total Voting Rights
In accordance with the FCA’s Disclosure Guidance and Transparency Rule 5.6.1, the Company announces that on 31 October 2026 it had the following ordinary shares of 0.3 pence each in the capital of the Company:
|
Total Issued Share Capital
|
128,860,145 |
|
Shares held in Treasury
|
9,993,387 |
|
Total Voting Rights |
118,866,758 |
Each Ordinary Share in issue carries one vote while Ordinary Shares held in Treasury have no voting rights.
Accordingly, the total number of voting rights above may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA’s Disclosure and Transparency Rules.
For further information, please contact:
Venture Life Group PLC +44 (0) 1344 578004
Jerry Randall, Chief Executive Officer
Daniel Wells, Chief Financial Officer
Cavendish Capital Markets Limited (Nomad and Broker) +44 (0) 20 7720 0500
Stephen Keys/George Lawson (Corporate Finance)
Michael Johnson (Sales)
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on commercialising products for the global self-care market. Headquartered in the UK, the Group's product portfolio includes Balance Activ in the area of women's intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, the Health & Her/Him product ranges supporting the hormonal lifecycle, FemiClear products addressing a range of common gynaecological conditions, plus the Curoxen brand providing infection prevention solutions for wounds and mouth sores.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally. In the UK, Ireland and the USA these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 hour ago Galantas Gold Corp.
- 1 hour ago Legal & General Group
- 2 hours ago Inchcape
- 2 hours ago Elementis
- 2 hours ago Taylor Maritime Investments Limited NPV